Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
NCT04090801 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-09-26
Summary
The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.
Conditions
- Female Pattern Hair Loss
Interventions
- DRUG
-
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol
- DRUG
-
Topical minoxidil 5% in pure ethanol alone
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
- OTHER
-
Placebo (Ethanol)
The treatment will be continued twice daily.for six months with regular visits at 3 months intervals.
Sponsors & Collaborators
-
Sohag University
lead OTHER
Principal Investigators
-
Mohammed Abu El-Hamd, MD · Faculty of Medicine, Sohag University, Egypt.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-30
- Primary Completion
- 2016-05-30
- Completion
- 2017-01-23
More Related Trials
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
NCT05888922 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia
NCT01650272 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia
NCT02460497 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
NCT07011485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
NCT01655108 ·Status: UNKNOWN ·Phase: PHASE3
-
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
NCT02486848 ·Status: WITHDRAWN ·Phase: NA
-
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
NCT03488108 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
NCT01391156 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Minoxidil Foam Versus Placebo Foam for Androgenetic Alopecia
NCT01319370 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
NCT05636904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
NCT05369481 ·Status: UNKNOWN ·Phase: NA
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
NCT06556056 ·Status: COMPLETED ·Phase: NA
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
NCT01662089 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
NCT02483195 ·Status: WITHDRAWN ·Phase: PHASE4
-
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia Areata
NCT05587257 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
NCT06218394 ·Status: RECRUITING ·Phase: NA
-
Hair Regeneration in Androgenetic Alopecia
NCT06066827 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
NCT06333600 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
NCT03004469 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
NCT03831334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1